---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-004203"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T06:12:55.403465+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Windtree Therapeutics enters warrant inducement agreement; receives ~$157K from exercise of existing warrants

## Summary
- Reduced exercise price of existing warrants to $0.1411 per share; holder exercises 1,112,308 shares for ~$157K.
- Issued new warrants to purchase up to 2,224,616 shares at $0.2152, exercisable after 6 months, expiring 5 years later.
- Engaged Ladenburg Thalmann as placement agent; fees of 8% of gross proceeds plus 1% management fee.
- New warrants have 19.99% beneficial ownership limitation; resale registration statement to be filed within 90 days.

## SEC filing metadata
- accession: 0001437749-23-004203
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/0001437749-23-004203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/wint20230222_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-004203
- JSON: https://secwatch.observer/filing/0001437749-23-004203.json
- Plain text: https://secwatch.observer/filing/0001437749-23-004203.txt

## Key facts
- Material Agreements
  WINDTREE THERAPEUTICS INC /DE/ entered into Inducement Letter with a certain holder (the "Exercising Holder") valued at approximately $157,000 (effective 2023-02-21).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain holder (the "Exercising Holder")
  - Value: approximately $157,000
  - Effective: 2023-02-21
  source text: On February 21, 2023, Windtree Therapeutics, Inc. (the "Company") entered into a warrant exercise inducement offer letter (the "Inducement Letter") with a certain holder (the "Exercising Holder") of certain of the Company’s: (i) warrants issued in July 2018 to purchase 62,500 shares of common stock, par value $0.001 per share ("Common Stock"), with an exercise price of $12.00 per share (the "July 2018 Warrants"); (ii) warrants issued in December 2018 to purchase 498,008 shares of Common Stock with an exercise price of $12.15 per share (the "December 2018 Warrants"); (iii) warrants issued in December 2019 to purchase 275,938 shares of Common Stock with an exercise price of $12.09 per share (the "December 2019 Warrants"); and (iv) warrants issued in May 2020 to purchase 275,862 shares of Common Stock with an exercise price of $7.975 per share (the "May 2020 Warrants", and together with the July 2018 Warrants, December 2018 Warrants and December 2019 Warrants, the "Existing Warrants").
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923004203/0001437749-23-004203-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.